The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. Keeping that in mind, here are three stocks where Wall Street’s estimates seem disconnected from reality and some better opportunities to consider.
Resideo (REZI)
Consensus Price Target: $49.33 (34.4% implied return)
Resideo Technologies, Inc. (NYSE: REZI) is a manufacturer and distributor of technology-driven products and solutions for home comfort, energy management, water management, and safety and security.
Why Do We Think Twice About REZI?
- 7.5% annual revenue growth over the last five years was slower than its industrials peers
- 20.7 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
- Waning returns on capital imply its previous profit engines are losing steam
Resideo is trading at $36.70 per share, or 11.5x forward P/E. To fully understand why you should be careful with REZI, check out our full research report (it’s free).
UFP Technologies (UFPT)
Consensus Price Target: $324.50 (25.8% implied return)
With expertise dating back to 1963 in specialized materials and precision manufacturing, UFP Technologies (NASDAQ: UFPT) designs and manufactures custom solutions for medical devices, sterile packaging, and other highly engineered products for healthcare and industrial applications.
Why Does UFPT Fall Short?
- Modest revenue base of $608.9 million gives it less fixed cost leverage and fewer distribution channels than larger companies
- Adjusted operating margin was unchanged over the last two years, suggesting it failed to gain leverage on its fixed costs
At $257.86 per share, UFP Technologies trades at 23.7x forward P/E. If you’re considering UFPT for your portfolio, see our FREE research report to learn more.
CoStar (CSGP)
Consensus Price Target: $44.05 (67.2% implied return)
With a research department that makes over 10,000 property updates daily to its 35-year-old database, CoStar Group (NASDAQ: CSGP) provides comprehensive real estate data, analytics, and online marketplaces for commercial and residential properties in the U.S. and U.K.
Why Does CSGP Worry Us?
- Efficiency has decreased over the last five years as its adjusted operating margin fell by 16.3 percentage points
- Free cash flow margin shrank by 10.8 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
CoStar’s stock price of $26.35 implies a valuation ratio of 18.2x forward P/E. Dive into our free research report to see why there are better opportunities than CSGP.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
